We described here the study methods briefly. We extracted genomic DNA from fecal samples by treating them with achromopeptidase (Wako Pure Chemical Industries, Tokyo, Japan) [20 ]. We amplified the V1–V2 16S rRNA gene region by primers according to a procedure reported previously [21 (link)]. We purified (AMPure XP magnetic purification beads, Beckman Coulter, Tokyo, Japan), quantified (Agilent 2100 Bioanalyzer, Agilent Technologies Japan, Tokyo, Japan), and sequenced the amplicon libraries (Ion Torrent PGM, Life Technologies Japan, Tokyo, Japan).
Gut Microbiome Analysis in Retinitis Pigmentosa
We described here the study methods briefly. We extracted genomic DNA from fecal samples by treating them with achromopeptidase (Wako Pure Chemical Industries, Tokyo, Japan) [20 ]. We amplified the V1–V2 16S rRNA gene region by primers according to a procedure reported previously [21 (link)]. We purified (AMPure XP magnetic purification beads, Beckman Coulter, Tokyo, Japan), quantified (Agilent 2100 Bioanalyzer, Agilent Technologies Japan, Tokyo, Japan), and sequenced the amplicon libraries (Ion Torrent PGM, Life Technologies Japan, Tokyo, Japan).
Corresponding Organization : Self-Defense Forces Central Hospital
Variable analysis
- RP patients vs. normal individuals
- 16S rRNA metagenomic data
- Mean age of RP patients: 54.8 ± 2.8 years
- Mean age of normal individuals: 52.8 ± 2.8 years
- Male to female ratio in RP patients: 7:18
- Male to female ratio in normal individuals: 12:15
- Mean age of disease onset in RP patients: 44.8 ± 3.4 years
- Mean disease duration in RP patients: 10.0 ± 1.6 years
- No positive or negative controls were explicitly mentioned in the information provided.
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!